HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy

by on 5 d'octubre de 2020 with No hi ha comentaris
  • Blanch-Lombarte, O., Santos, J. R., Peña, R., Jiménez-Moyano, E., Clotet, B., Paredes, R., i Prado, J. G. (2020). HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy. The Journal of antimicrobial chemotherapy, 75(9), 2535-2546. https://doi.org/10.1093/jac/dkaa228

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *